Nasal COVID vaccine fails to offer desired protection in testing
A recent clinical trial has found less-than-promising results for a nasally administered version of AstraZenecas COVID-19 vaccine, with immune responses only observed in a minority
Tuesday, October 11, 2022 at 7:58 pm